ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Mrs. Amira - Cancer of the liver

Patient Basic Information Patient: Ms. Amira Young) Nationality: Djibouti Diagnosis: Esophageal Cancer Diagnostic Hospital: H0oC Treatment Scheme: Insulinary Treatment + Medicines Accommodation Day: 180 days Treatment cost: approximately 1394693 yuan Treatment effect: Complete relief The patient is from Djibouti and was diagnosed with esophageal cancer locally. Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on patient inspection reports and physical conditions, and provided translation, escort and on-site services throughout the treatment process.

After 180 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard. The patient's treatment effects were finally completely alleviated. When he left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him, and continued to monitor the recovery through the remote follow-up system.

'Mrs. Liu Amira, experts have criticized this case as a typical case of cross-border suspected seriousness clinical cases. Liu4 is a multidisciplinary collaborative mechanism that has developed an intracellular treatment+ drug program for esophageal cancer, reflecting the comprehensive strength of Chinese hospitals in the field of suspected disease clinics, and a summary of how international medical services are regulated.

(Figure from Liu5 official news reports and medical scenarios)

吉布提,食管癌,山东大学齐鲁医院,国际医疗,来华就医,中国医疗